)
)
ImmunoPrecise Antibodies Investor Relations Material
Latest events
Q2 2025
ImmunoPrecise Antibodies
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from ImmunoPrecise Antibodies Ltd
Access all reports
Segment Data
Access more data
Revenue by
Geography
Europe
U.S.
Australia
Canada
Other
Expenses by
Financials
ImmunoPrecise Antibodies Ltd. engages in antibody production and related services worldwide. It offers purification and affinity maturation of monoclonal antibodies; design, development, and validation of comprehensive service packages for the discovery of novel antibodies against therapeutic targets; custom peptide synthesis services; recombinant protein expression platforms; custom vaccines and neutralizing antibodies for passive transfer applications; and an in vivo passive transfer model for assessing the efficacy of passive immune treatments targeting infectious diseases.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
IPA
Country
🇺🇸 United States